Clinical Trial: A Clinical Study of MK-1084 in People With Advanced Solid Tumors (MK-1084-014)

U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07209111) titled 'A Clinical Study of MK-1084 in People With Advanced Solid Tumors (MK-1084-014)' on Sept. 30.

Brief Summary: Researchers want to learn if MK-1084 given alone or with cetuximab can treat certain advanced solid tumors in people with the KRAS G12C mutation.

The goals of this study are to learn:

* How many people have the cancer respond (get smaller or go away) to MK-1084 alone or with cetuximab and how these responses compare

* About the safety of MK-1084 alone or with cetuximab and if people tolerate the treatments.

Study Start Date: Nov. 24

Study Type: INTERVENTIONAL

Condition: Neoplasm Malignant

Intervention: DRUG: MK-1084

O...